Testing effectiveness (Phase 2)Study completedNCT04744207
What this trial is testing
Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis
Who this might be right for
Systemic Sclerosis
Gesynta Pharma AB 94
Showing 5 of 5 results